Unknown OBSERVATIONAL NCT05856409

Clinical Application of 68Ga-FAPI PET Imaging in Detection of Ovarian Cancer Recurrence

Sponsor: RenJi Hospital

Conditions 68Ga-FAPI Epithelial Ovarian Cancer Ovarian Cancer Positron Emission Tomography

Interventions 68Ga-FAPI

Updated 5 times since 2023 Last updated: Aug 15, 2023 Started: May 10, 2023 Primary completion: Apr 1, 2024 Completion: Dec 31, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on 68Ga-FAPI and Epithelial Ovarian Cancer, this trial is ongoing. The trial is conducted by RenJi Hospital and has accumulated 5 data snapshots since 2023. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

5 versions recorded

Feb 2026 — Present [monthly]

Unknown

Status: Recruiting → Unknown
Sep 2024 — Feb 2026 [monthly]

Recruiting
Jul 2024 — Sep 2024 [monthly]

Recruiting
Sep 2023 — Jul 2024 [monthly]

Recruiting

Status: Not Yet Recruiting → Recruiting
Jun 2023 — Sep 2023 [monthly]

Not Yet Recruiting

First recorded

May 2023

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

RenJi Hospital

Data source: RenJi Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Shanghai, China